Stockholm, Sweden – April 1, 2010
Swedish Orphan Biovitrum (STO: BVT) has expanded its agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, for the distribution of Cyanokit® (hydroxocobalamin). Under the agreement the distribution territories will include Ireland, UK and The Netherlands in addition to the existing territories the Nordic and the Baltic countries.

Please read the whole press release here.